Also Try:
On Thursday, the FDA approved Bristol Myers Squibb & Co’s (NYSE:BMY) Cobenfy (xanomeline and trospium chloride, KarXT), an oral medication for schizophrenia ...
Benzinga via Yahoo
5 days ago
Insider Monkey via Yahoo
Bristol-Myers Squibb Company (BMY) is Driving Growth Through Strategic Acquisitions
16 hours ago
Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline
2 days ago
Reuters via Yahoo
Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
1 day ago
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
4 days ago
Bristol-Myers Squibb Company (BMY): Among the Dividend Giants with Lowest Short Interest in 2024
6 days ago
View all
American pharmaceutical company
bms.com
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company. Wikipedia
Stock price: BMY (NYSE) $52.90 +1.16 (+2.24%)
Tue, Oct 1, 2024, 4:00PM EDT